Defibrotide

Basic Information

Item Value
DrugBank ID DB04932
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 86

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 pseudo-von Willebrand disease KG + DL
2 primary release disorder of platelets KG + DL
3 Glanzmann thrombasthenia KG + DL
4 thrombotic thrombocytopenic purpura KG + DL
5 Scott syndrome KG + DL
6 bleeding diathesis due to a collagen receptor defect KG + DL
7 hemorrhagic disorder due to a constitutional thrombocytopenia KG + DL
8 congenital factor V deficiency KG + DL
9 fetal and neonatal alloimmune thrombocytopenia KG + DL
10 thrombocytopenic purpura KG + DL
11 inherited thrombophilia KG + DL
12 hepatic infarction KG + DL
13 peliosis hepatis KG + DL
14 familial apolipoprotein C-II deficiency KG + DL
15 syndrome with combined immunodeficiency KG + DL
16 platelet-type bleeding disorder KG + DL
17 Ehlers-Danlos syndrome, fibronectinemic type KG + DL
18 flood factor deficiency KG + DL
19 methylcobalamin deficiency type cblG KG + DL
20 Von Willebrand disease, X-linked form KG + DL
21 hereditary thrombocytosis with transverse limb defect KG + DL
22 familial thrombomodulin anomalies KG + DL
23 hemophilia KG + DL
24 atypical hemolytic-uremic syndrome with thrombomodulin anomaly KG + DL
25 neuropathy, painful KG + DL
26 von Willebrand disease KG + DL
27 acquired coagulation factor deficiency KG + DL
28 adenosine deaminase deficiency KG + DL
29 reticular dysgenesis KG + DL
30 congenital factor XIII deficiency KG + DL
31 autosomal dominant macrothrombocytopenia KG + DL
32 pancytopenia due to IKZF1 mutations KG + DL
33 combined immunodeficiency due to CRAC channel dysfunction KG + DL
34 severe combined immunodeficiency due to LCK deficiency KG + DL
35 factor XIII, A subunit, deficiency KG + DL
36 lipase deficiency, combined KG + DL
37 absent thumb-short stature-immunodeficiency syndrome KG + DL
38 facial dysmorphism-immunodeficiency-livedo-short stature syndrome KG + DL
39 liver angiosarcoma KG + DL
40 esophageal varices with bleeding KG + DL
41 esophageal varices without bleeding KG + DL
42 congenital factor XI deficiency KG + DL
43 inherited prekallikrein deficiency KG + DL
44 heparin cofactor 2 deficiency KG + DL
45 immuno-osseous dysplasia KG + DL
46 thrombophilia due to protein S deficiency, autosomal dominant KG + DL
47 autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis KG + DL
48 autosomal dominant familial periodic fever KG + DL
49 varicose disease KG + DL
50 primary immunodeficiency due to a defect in adaptive immunity KG + DL

(Showing top 50 of 86 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). This report is for research purposes only and does not constitute medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.